Long-term pain relief produced by intrathecal morphine infusion in 53 patients.

The present report details the characteristics of the analgesic effects of morphine administered chronically by infusion pumps implanted in 53 patients suffering from terminal metastatic disease. The median postimplant survival time in these patients was 4 months. Patients (mean age 58 years) were characterized according to the duration of pain before pump implantation (mean 16 months), prior consumption of systemic opioids (mean one to six daily analgesic equivalents of morphine), and their response to a trial intrathecal dose of morphine (1 to 2 mg). The median infusion dose at 2 weeks was 3.8 mg/day. The analgesic index, calculated as (quality of pain relief x duration of pain relief in hours)/morphine dose in mg, that was observed after the trial dose of morphine was determined for each patient. A close correlation was observed between the acute (2-week) infusion dose necessary to produce pain relief and the analgesic index such that the infusion dose = -8.0 x log (analgesic index) + 17.1. By 16 weeks, the mean spinal morphine dose for the group had increased by a factor of about 2.5; however, significant variation in the dose incrementation was documented. The maximum increase was observed in patients with a low analgesic index, and this rapid incrementation was usually correlated with an unsatisfactory overall outcome. Evidence that long-term infusion continues to yield analgesia was evidenced in six cases where there was an unanticipated loss of drug infusion and a corresponding increase in parenteral narcotic consumption. These data indicate the long-term efficacy and safety of spinal opioid infusion in patients with terminal cancer, and emphasize the advantage of assessing the sensitivity of the patient to spinal opioids by a standardized trial injection prior to pump placement as a prognostic indication of outcome.

[1]  T. Yaksh,et al.  Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. , 1989, The Journal of pharmacology and experimental therapeutics.

[2]  T. Yaksh.  Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists , 1989, Pain.

[3]  T. Yaksh,et al.  Receptors in the Dorsal Horn and Intrathecal Drug Administration , 1988, Annals of the New York Academy of Sciences.

[4]  T. Yaksh,et al.  Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. , 1988, The Journal of pharmacology and experimental therapeutics.

[5]  R. Meyer,et al.  Myelinated afferents signal the hyperalgesia associated with nerve injury , 1988, Pain.

[6]  R. Penn.  Neurological applications of implanted drug pumps. , 1988, Annals of the New York Academy of Sciences.

[7]  T. Yaksh,et al.  Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. , 1988, The Journal of pharmacology and experimental therapeutics.

[8]  G. Brazenor.  Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion by implanted pump. , 1987, Neurosurgery.

[9]  K. Foley,et al.  Paradoxical pain following high-dose spinal morphine , 1987, PAIN.

[10]  T. Yaksh,et al.  Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians , 1987, Pain.

[11]  R. North,et al.  Cellular mechanisms of opioid tolerance: studies in single brain neurons. , 1987, Molecular pharmacology.

[12]  T. Hedner,et al.  CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief , 1987, Pain.

[13]  D. Wermeling,et al.  Drug delivery for intractable cancer pain. Use of a new disposable parenteral infusion device for continuous outpatient epidural narcotic infusion , 1987, Cancer.

[14]  R. Penn,et al.  Chronic intrathecal morphine for intractable pain. , 1987, Journal of neurosurgery.

[15]  N. Rawal,et al.  Present state of extradural and intrathecal opioid analgesia in Sweden. A nationwide follow-up survey. , 1987, British journal of anaesthesia.

[16]  W. Watkins,et al.  Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors. , 1987, The Journal of pharmacology and experimental therapeutics.

[17]  S. Waldman,et al.  Selection of Patients for Implantable Intraspinal Narcotic Delivery Systems , 1986, Anesthesia and analgesia.

[18]  K. Foley.  The treatment of pain in the patient with cancer , 1986, CA: a cancer journal for clinicians.

[19]  A. Shetter,et al.  Administration of intraspinal morphine sulfate for the treatment of intractable cancer pain. , 1986 .

[20]  R. Saunders,et al.  Continuous intrathecal hydromorphone and clonidine for intractable cancer pain. , 1986, Journal of neurosurgery.

[21]  E. El-Fakahany,et al.  Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. , 1986, European journal of pharmacology.

[22]  T. Yaksh,et al.  High Doses of Spinal Morphine Produce a Nonopiate Receptormediated Hyperesthesia: Clinical and Theoretic Implications , 1986, Anesthesiology.

[23]  A. Caputy,et al.  Long-term, intermittent percutaneous administration of epidural and intrathecal morphine for pain of malignant origin. , 1986, The American surgeon.

[24]  D. Wilkie,et al.  Intrathecal d-Ala2-d-Leu5-enkephalin (DADL) restores analgesia in a patient analgetically tolerant to intrathecal morphine sulfate , 1986, Pain.

[25]  T. Yaksh,et al.  Studies of the Pharmacology and Pathology of Intrathecally Administered 4‐Anilinopiperidine Analogues and Morphine in the Rat and Cat , 1986, Anesthesiology.

[26]  T. Yaksh,et al.  Epidural Injections of Bupivacaine, Morphine, Fentanyl, Lofentanil, and DADL in Chronically Implanted Rats: A Pharmacologic and Pathologic Study , 1986, Anesthesiology.

[27]  M. Max,et al.  The analgesic efficacy of intrathecal d-ala2-d-leu5-enkephalin in cancer patients with chronic pain , 1985, Pain.

[28]  D. Nierenberg,et al.  Neuropathologic lesions and CSF morphine concentrations during chronic continuous intraspinal morphine infusion. A clinical and post-mortem study , 1985, Pain.

[29]  E. Krames,et al.  Continuous infusion of spinally administered narcotics for the relief of pain due to malignant disorders , 1985, Cancer.

[30]  R. Catane,et al.  Continuous epidural narcotic analgesia for intractable pain due to malignancy , 1985, Journal of surgical oncology.

[31]  M. Cousins,et al.  A Technique for the Insertion of an Implantable Portal System for the Long-Term Epidural Administration of Opioids in the Treatment of Cancer Pain , 1985, Anaesthesia and intensive care.

[32]  T. Yaksh.  Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing , 1985, Pharmacology Biochemistry and Behavior.

[33]  Josef K. Wang.  Intrathecal morphine for intractable pain secondary to cancer of pelvic organs , 1985, Pain.

[34]  B. Malone,et al.  Management of pain in the terminally III by administration of epidural narcotics , 1985, Cancer.

[35]  S. Arnér,et al.  Differential Effects of Epidural Morphine in the Treatment of Cancer‐related Pain , 1985, Acta anaesthesiologica Scandinavica.

[36]  A. Muller,et al.  Analgésie par site implantable pour injections intrathécales itératives de morphine , 1985 .

[37]  T. Yaksh,et al.  The physiology and pharmacology of spinal opiates. , 1985, Annual review of pharmacology and toxicology.

[38]  C. Chavkin,et al.  Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Cousins Mj,et al.  Intrathecal and epidural administration of opioids , 1984 .

[40]  R. Penn,et al.  Cancer pain relief using chronic morphine infusion. Early experience with a programmable implanted drug pump. , 1984, Journal of neurosurgery.

[41]  B. N. French,et al.  Intrathecal morphine for pelvic and sacral pain caused by cancer. , 1984, Surgical neurology.

[42]  L. Mather,et al.  Intrathecal and epidural administration of opioids. , 1984, Anesthesiology.

[43]  R. Harbaugh,et al.  Relief of continuous chronic pain by intraspinal narcotics infusion via an implanted reservoir. , 1983, JAMA.

[44]  T. Yaksh.  In vivo studies on spinal opiate receptor systems mediating antinociception. I. Mu and delta receptor profiles in the primate. , 1983, The Journal of pharmacology and experimental therapeutics.

[45]  B. Onofrio,et al.  INTRATHECAL DELTA-RECEPTOR LIGAND PRODUCES ANALGESIA IN MAN , 1983, The Lancet.

[46]  T. Burks,et al.  Affinity of normorphine for its pharmacologic receptor in the naive and morphine-tolerant guinea-pig isolated ileum. , 1983, Journal of Pharmacology and Experimental Therapeutics.

[47]  M. Hadani,et al.  Continuous epidural morphine treatment for intractable pain in terminal cancer patients , 1982, Pain.

[48]  R. Twycross,et al.  Pain in far-advanced cancer , 1982, Pain.

[49]  W. Ensminger,et al.  Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. , 1982, Journal of neurosurgery.

[50]  K. Foley.  The practical use of narcotic analgesics. , 1982, The Medical clinics of North America.

[51]  M. Chauvin,et al.  Postoperative Spinal Analgesia with Morphine , 1982 .

[52]  T. Yaksh,et al.  Continuous Low-Dose Intrathecal Morphine Administration in the Treatment of Chronic Pain of Malignant Origin , 1982 .

[53]  G. Hempelmann,et al.  Epidural Opiates for Relief of Cancer Pain , 1982 .

[54]  P. Tomlin,et al.  Narcotic withdrawal syndrome after intrathecal administration of morphine. , 1981, British medical journal.

[55]  T. Yaksh,et al.  Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. , 1981, Anesthesiology.

[56]  C. Woolf.  Intrathecal high dose morphine produces hyperalgesia in the rat , 1981, Brain Research.

[57]  P. Winter,et al.  Opiate withdrawal syndrome following intrathecal administration of morphine. , 1980, Anesthesiology.

[58]  T. Yaksh,et al.  Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. , 1977, European journal of pharmacology.

[59]  R. Corcoran,et al.  POLYCYSTIC OVARIAN DISEASE AND ORAL CONTRACEPTION , 1975, The Lancet.